Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/90443
Title: | Thrombospondin-1 mediates Rho-kinase inhibitor-induced increase in outflow-facility | Authors: | Shan, SW Do, CW Lam, TC Li, HL Stamer, WD To, CH |
Issue Date: | Dec-2021 | Source: | Journal of cellular physiology, Dec. 2021, v. 236, no. 12, p. 8226-8238 | Abstract: | Rho-kinase (ROCK) inhibitors, a novel class of anti-glaucoma agents, act by increasing the aqueous humor outflow through the conventional trabecular meshwork pathway. However, the downstream signaling consequences of the ROCK inhibitor are not completely understood. Our data show that Y39983, a selective ROCK inhibitor, could induce filamentous actin remodeling, reduced cell motility (as measured by cell migration), and transepithelial resistance in primary human TM (hTM) cells. After 2 days Y39983 treatment of hTM cells, a proteomic study identified 20 proteins whose expression was significantly altered. Pathway analysis of those proteins revealed the involvement of the p53 pathway, integrin signaling pathway, and cytoskeletal pathway regulation by Rho GTPase. Thrombospondin-1 (TSP1), a matricellular protein that is increased in glaucoma patients, was downregulated fivefold following Y39983 treatment. More importantly, both TSP1 antagonist leucine–serine–lysine–leucine (LSKL) and small interfering RNA (siRNA) reduced TSP1 gene and protein expressions as well as hTM cell migration. In the presence of Y39983, no further inhibition of cell migration resulted after LSKL and TSP1 siRNA knockdown. Likewise, LSKL triggered a dose-dependent increase in outflow facility in ex vivo mouse eyes, to a similar extent as Y39983 (83.8% increase by Y39983 vs. 71.2% increase by LSKL at 50 µM). There were no additive effects with simultaneous treatment with LSKL and Y39983, supporting the notion that the effects of ROCK inhibition were mediated by TSP1. | Keywords: | Glaucoma Outflow facility ROCK inhibitor Thrombospondin-1 Trabecular meshwork |
Publisher: | John Wiley & Sons | Journal: | Journal of cellular physiology | ISSN: | 0021-9541 | EISSN: | 1097-4652 | DOI: | 10.1002/jcp.30492 | Rights: | This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. © 2021 Authors. Journal of Cellular Physiology published by Wiley Periodicals LLC The following publication Shan, S., Do, C., Lam, T. C., Li, H., Stamer, W. D., & To, C. (2021). Thrombospondin-1 mediates Rho-kinase inhibitor-induced increase in outflow-facility. J Cell Physiol, 236, 8226– 8238 is available at https://dx.doi.org/10.1002/jcp.30492 . |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Shan_Thrombospondin-1_Rho-Kinase_Outflow-Facility.pdf | 2.61 MB | Adobe PDF | View/Open |
Page views
90
Last Week
0
0
Last month
Citations as of May 5, 2024
Downloads
21
Citations as of May 5, 2024
SCOPUSTM
Citations
7
Citations as of Apr 26, 2024
WEB OF SCIENCETM
Citations
6
Citations as of May 2, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.